Alteration of apelin cleavage sites generates apelin-dm peptide that effectively represses the malignant and metastatic phenotype of cancer cells and angiogenesis through modulation of apelin receptor dynamics, affinity, internalization, and diverse apelin signaling pathways. This evidence concerns the gene APLN and cancer.